News Archive

/static/apps/cms/news/1683/M1.png

NIH Featuring CPTAC Investigators: Marcin Cieslik

September 4, 2025 / Mctp
Featuring CPTAC Investigators: Marcin Cieslik Original Article: Q&A with Marcin Cieslik, Ph.D. - NCI The following is the ninth entry in a Q&A series highlighting selected Clinical Proteomic Tumor Analysis Consortium (CPTAC) researchers and their work. Join us as we discuss CPTAC, the importance of collaboration in science, and advice for the next generation of researchers with Marcin Cieslik, Ph.D., an Assistant Professor and Division
FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/1084/man-looking-in-microscope-500x500.jpg

Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead

December 22, 2020 / Cancer Research

Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus. wo proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, MD, PhD. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers [...]

FULL STORY
https://www.pathology.med.umich.edu/static/apps/cms/889/nih-sq.jpg

Updated NIH Policy Statement Emphasizes "Other Support" Reporting

December 20, 2019 / Research

All faculty who serve as the Principal Investigator or one of the key personnel on an NIH award or pending proposal are required to review their new guidance and address the two parts below, as appropriate, by January 20, 2020 [...]

FULL STORY